Litcius/Paper detail

Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia

Courtney D. DiNardo, Wei‐Ying Jen, Koichi Takahashi, Tapan M. Kadia, Sanam Loghavi, Naval Daver, Lianchun Xiao, Patrick K. Reville, Ghayas C. Issa, Nicholas J. Short, Koji Sasaki, Sa A. Wang, Jillian Mullin, Sherry Pierce, Corey Bradley, Gautam Borthakur, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Alessandra Ferrajoli, Mahesh Swaminathan, Maro Ohanian, Hussein A. Abbas, Danielle Hammond, Jan A. Burger, Fadi Haddad, Guillermo Montalban‐Bravo, Kelly S. Chien, Lucia Masárová, Musa Yılmaz, Nitin B. Jain, Michael Andreeff, Guillermo Garcia‐Manero, Steven M. Kornblau, Farhad Ravandi, Elias Jabbour, Marina Konopleva, Hagop M. Kantarjian

2025Leukemia35 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHematopoietic stem cell transplantationInduction chemotherapyMyeloid leukemiaTransplantationOncologyFlag (linear algebra)CohortSalvage therapyGastroenterologyChemotherapyMathematicsAlgebra over a fieldPure mathematicsAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationMultiple Myeloma Research and Treatments
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia | Litcius